Oruka Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 13 Sep 24 | Buy€1,555,778 | Adage Capital Management, L.P. | Company | 75,000 | €20.74 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 944,697 | 2.7% |
| Private Companies | 2,500,000 | 7.14% |
| VC/PE Firms | 3,085,620 | 8.82% |
| General Public | 4,671,029 | 13.3% |
| Hedge Funds | 5,062,570 | 14.5% |
| Institutions | 18,734,634 | 53.5% |
Dilution of Shares: HQ1 only recently listed within the past 12 months
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,512,300 | €97.5m | 17.7% | 0.01% | |||
| 3,211,922 | €56.8m | 0% | 5.33% | |||
| 3,085,620 | €54.6m | 0% | 3.02% | |||
| 2,500,000 | €44.2m | 0% | no data | |||
| 1,850,648 | €32.7m | 0% | 0.52% | |||
| 1,491,646 | €26.4m | 0% | no data | |||
| 1,369,714 | €24.2m | 0% | 1.88% | |||
| 1,235,187 | €21.9m | 0% | 0.55% | |||
| 1,235,187 | €21.9m | 0% | 0.77% | |||
| 852,338 | €15.1m | 0% | no data | |||
| 790,926 | €14.0m | 0% | 0.9% | |||
| 720,547 | €12.7m | 0% | 0.01% | |||
| 719,660 | €12.7m | 0% | 0.51% | |||
| 515,726 | €9.1m | 0% | 0.46% | |||
| 514,659 | €9.1m | 0% | 3.81% | |||
| 482,330 | €8.5m | 0% | 0.02% | |||
| 477,327 | €8.4m | 0% | 0.39% | |||
| 411,728 | €7.3m | 0% | 0.46% | |||
| 390,795 | €6.9m | 0% | 0.07% | |||
| 375,330 | €6.6m | 0% | 1.48% | |||
| 349,836 | €6.2m | 0% | 1.23% | |||
| 333,371 | €5.9m | 0% | 8.0% | |||
| 308,795 | €5.5m | 0% | 0.04% | |||
| 279,648 | €4.9m | 0% | no data | |||
| 257,330 | €4.6m | 0% | 0.62% |